Headlines
  • False or misleading informations are spread by organizations posing as legitimate media outlets in an attempt to twist public opinion in favor of a certain ideology.
  • On social media,watch out for fake messages,pictures,Videos and news.
  • Always Check Independent Fact Checking Sites if You Have Some Doubts About the Authenticity of Any Information or Picture or video.
  • Check Google Images for AuthThe Google Reverse Images search can helps you.
  • It Would Be Better to Ignore Social Media Messages that are forwarded from Unknown or Little-Known Sources.
  • If a fake message asks you to share something, you can quickly recognize it as fake messege.
  • It is a heinous crime and punishable offence to post obscene, morphed images of women on social media networks, sometimes even in pornographic websites, as retaliation.
  • Deepfakes use artificial intelligence (AI)-driven deep learning software to manipulate preexisting photographs, videos, or audio recordings of a person to create new, fake images, videos, and audio recordings.
  • AI technology has the ability to manipulate media and swap out a genuine person's voice and likeness for similar counter parts.
  • Deepfake creators use this fake substance to spread misinformation and other illegal activities.Deepfakes are frequently used on social networking sites to elicit heated responses or defame opponents.
  • One can identify AI created fake videos by identifying abnormal eye movement, Unnatural facial expressions, a lack of feeling, awkward-looking hand,body or posture,unnatural physical movement or form, unnatural coloring, Unreal-looking hair,teeth that don't appear natural, Blurring, inconsistent audio or noise, images that appear unnatural when slowed down, differences between hashtags blockchain-based digital fingerprints, reverse image searches.
  • Look for details,like stange background,orientation of teeth,handsclothing,asymmetrical facial features,use reverse image search tools.

More Details

Breakthrough Made in Treating Ebola Virus

In northeastern Congo, more than 600 people have fallen ill with the Ebola virus, and at least 368 people have died from the disease. It’s been difficult to contain the virus because of conflict in the region, despite medical advances, including a vaccine.

The Democratic Republic of Congo is where Ebola was first discovered in 1976, when the country was called Zaire. The disease was named after the Ebola River where the virus was spreading. Between then and 2013, there was no treatment or a vaccine. The outbreak ran its course in quarantined communities.

Scientists started studying the virus, however, trying to come up with better ways to handle its various deadly strains. They succeeded in producing a vaccine to help end the Ebola epidemic that swept through three West African countries between 2013 and 2016. More than 11,000 people died in that outbreak.

Treatment found

At that time, treatment for the Zaire strain of Ebola was developed. It was costly to produce and didn’t work on two other lethal strains, the Sudan and Bundibugyo viruses.

But now scientists have found one. Their research produced a drug cocktail called MBP134 that helped monkeys infected with three deadly strains of Ebola recover from the disease.

What’s more, the treatment requires a single intravenous injection.

Thomas Geisbert, Ph.D., led the research at the University of Texas Medical Branch, part of a public-private partnership that also included Mapp Biopharmaceuticals, the U.S. Army Research Institute of Infectious Diseases, and the Public Health Agency of Canada.

Must treat all strains

In an interview with VOA, Geisbert stressed the need for a treatment that would be effective against all strains of Ebola.

“When an outbreak occurs, we really don’t know which one of those three strains, species, we call them, is the cause of that particular episode,” Geisbert said.
He added that the treatments available have been effective only against the Zaire species, which leaves people infected with the other species unprotected.

“Our goal was to develop a treatment that would work regardless of the particular strain of Ebola that was causing it,” Geisbert said.

“If I have to make a drug that only works against Zaire, and another drug that only works against Sudan and another drug that only works against the Bundibugyo species, that is extremely expensive,” he added.
Geisbert said the treatment will save valuable time in determining which strain of Ebola is circulating in a particular outbreak. It will save lives because people can be treated immediately, and it will also save money.

No profit

There’s no profit for the pharmaceutical companies that produce the drugs.
“It’s not like you’re making up vaccine for flu where companies [are] going to make a profit. There’s really a small global market for Ebola so it really has to be sponsored by the government,” he said.

In addition to the U.S. Army and the Canadian government, the U.S. National Institutes of Health has supported much of this research.

Geisbert said the work ahead involves tweaking the dose to its lowest possible amount, making it easier to distribute — again to reduce costs — and conducting clinical trials in humans to ensure the treatment is safe and effective.

Geisbert is confident it will work in humans, although he cautioned that in science, nothing is certain.

The treatment may not be ready to help those with Ebola in the Congo outbreak, but the promise is that countries affected by the virus could have the treatment at the ready to stop future Ebola outbreaks.
It also means that should someone with Ebola walk into a hospital outside of Africa, as happened in Texas when a Liberian man sought treatment, the patient can be cured, and health care workers can be protected~VOA

Related Article

Guterres Visited Ebola Center in DRC

The UN chief travelled to Mangina, a rural commune in Beni territory where the first case of Ebola w ...
September 2, 2019

New Treatment of Ebola

The mortality rate for REGN-EB3 and mAb114 was 29 per cent and 34 per cent respectively, and the dru ...
August 13, 2019

WHO: Low-Cost Generic Drugs Can Eliminate…

The WHO study finds hepatitis could be eliminated as a public health threat in 67 low-and middle-inc ...
July 27, 2019

Few Countries Implementing Life-Saving Anti-Tobacco Measures

A survey found 36 countries have introduced one or more measures aimed at helping people quit smokin ...

Global HIV Report by UNAIDS

Globally, around 1.7 million people became newly infected with HIV in 2018, a 16 percent decline sin ...
July 16, 2019

Twenty Million Children Worldwide Missed Out…

Since 2000, WHO and UNICEF jointly produce national immunization coverage estimates for Member State ...

Other Article

News & Views

Mary Jane Veloso, a Filipina on…

Mary Jane Veloso, a Filipina who has spent 14 years on death row in Indonesia, will be coming home b ...
November 21, 2024
Video Report

Trapped in Lebanon, African Migrants Face…

Many of the estimated 176,000 migrants living in Lebanon are African women who are working menial jo ...
Pick of the Day

Permanent Representative of France Briefs Press…

Nicolas de Rivière,Permanent Representative of France to the United Nations, briefs reporters after ...
November 20, 2024
Video Report

The Impact on a Ukrainian Family…

This week marks 1,000 days of fighting in Ukraine.For millions of Ukrainians, including 32-year-old ...
Pick of the Day

UN Security Council Meets to Discuss…

James Kariuki,Deputy Permanent Representative of the United Kingdom to the United Nations and Presid ...
November 19, 2024
Video Report

Syrian Refugees in Lebanon Flee Bombs

Over half a million people, many of them were refugees who initially fled the Syrian conflict, have ...

[wp-rss-aggregator feeds="crime-more-world"]
Top